Diagnostic Utility of the Germinal Center–associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Applied immunohistochemistry & molecular morphology (Print)

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/PAI.0000000000000107PMID 25203428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype

  2014cited by this paper
• Hodgkin Lymphoma: Pathology, Pathogenesis, and a Plethora of Potential Prognostic Predictors

  2014cited by this paper
• Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation

  2012cited by this paper
• Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non‐haematopoietic tumours using a newly developed rabbit monoclonal antibody

  2012cited by this paper
• Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma

  2011cited by this paper
• Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.

  2011cited by this paper
• LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome

  2011cited by this paper
• High expression of LMO2 in Hodgkin, Burkitt and germinal center diffuse large B cell lymphomas.

  2011cited by this paper
• Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas

  2011cited by this paper
• Diagnosis of Burkitt lymphoma using an algorithmic approach – applicable in both resource‐poor and resource‐rich countries

  2011cited by this paper
• Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.

  2011cited by this paper
• Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.

  2010cited by this paper
• Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores

  2010cited by this paper
• BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin’s lymphoma from primary mediastinal large B‐cell lymphoma

  2010cited by this paper
• The expression of LMO2 protein in acute B-cell and myeloid leukemia

  2010cited by this paper
• Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components

  2010cited by this paper
• Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases.

  2009cited by this paper
• Diagnostic Utility of the B-cell Lineage Markers CD20, CD79a, PAX5, and CD19 in Paraffin-embedded Tissues From Lymphoid Neoplasms

  2009cited by this paper
• Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.

  2009cited by this paper
• The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

  2009cited by this paper
• Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.

  2009cited by this paper
• Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma

  2008cited by this paper
• Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.

  2008cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.

  2007cited by this paper
• Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.

  2005cited by this paper
• Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

  2004cited by this paper
• Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.

  2004cited by this paper
• Identification of centerin: a novel human germinal center B cell‐restricted serpin

  2000cited by this paper
• The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.

  1994cited by this paper
• The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.

  1991cited by this paper

• Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

  2026cites this paper
• Composite chronic lymphocytic leukemia and mantle cell lymphoma involving the bone marrow: a case report and literature review

  2025cites this paper
• Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review

  2024cites this paper
• Burkitt Lymphoma.

  2024cites this paper
• Dedicated diagnostic approaches for mature B‐cell non‐Hodgkin lymphomas occurring in children, adolescents, and young adults

  2024cites this paper
• Bridging Clinicopathologic Features and Genetics in Follicular Lymphoma: Towards Enhanced Diagnostic Accuracy and Subtype Differentiation.

  2024cites this paper
• The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment

  2023cites this paper
• Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma

  2023cites this paper
• Value of GCET1, HGAL (GCET2), and LMO2 in the Determination of Germinal Center Phenotype in Diffuse Large B-cell Lymphoma

  2023influential citation
• Follicular Lymphoma in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Biological Data

  2023cites this paper
• Burkitt lymphoma

  2022cites this paper
• Basic immunohistochemistry for lymphoma diagnosis

  2022cites this paper
• Follicular lymphoma: updates for pathologists

  2021cites this paper
• Classic Hodgkin Lymphoma - Old Disease, New Directions: An Update on Pathology, Molecular Features and Biological Prognostic Markers.

  2021cites this paper
• Lymphomas and Other Rare Tumors of the Thymus

  2020cites this paper
• Small B-Cell Lymphomas With and Without Plasmacytic Differentiation

  2020cites this paper
• Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements

  2020cites this paper
• LIM domain only 2 (LMO2) expression distinguishes T‐lymphoblastic leukemia/lymphoma from indolent T‐lymphoblastic proliferations

  2020cites this paper
• Atlas of Thymic Pathology

  2020cites this paper
• Follicular Lymphoma and Mantle Cell Lymphoma: Pathobiology, Diagnosis and Treatment

  2020cites this paper
• Hepatic follicular lymphoma in an old patient with Crohn's disease: a rare case and review of the literature.

  2020cites this paper
• Follicular Lymphoma: Definition, Epidemiology, Pathobiology – Lymphomagenesis, Morphology, Variants, Immunophenotype, Prognostic Factors, Transformation

  2020cites this paper
• A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma

  2019cites this paper
• An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist’s perspective

  2019cites this paper
• Immunostains: Hematopoietic System

  2019cites this paper
• The accuracy of diagnosing Burkitt lymphoma in serous effusion specimen: A cytological‐histological correlation with ancillary studies

  2019cites this paper
• Follicular Lymphoma Diagnostic Caveats and Updates.

  2018cites this paper
• Small B-Cell Lymphomas

  2018cites this paper
• Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas

  2018cites this paper
• T-lymphoblastic lymphoma after previous thymoma: how NGS helps establishing the diagnosis and procures new insights

  2018cites this paper
• J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

  2017cites this paper
• Handbook of Practical Fine Needle Aspiration and Small Tissue Biopsies

  2017cites this paper
• Diagnostic Algorithm of Common Mature B-Cell Lymphomas by Immunohistochemistry.

  2017cites this paper
• „Echte Thymushyperplasie“

  2017cites this paper
• Thymic Epithelial Tumors and Benign Thymic Lesions

  2017cites this paper
• LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas

  2017cites this paper
• Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review

  2016cites this paper
• Genetic background of relapsing lymphoid neoplasms : comprehensive genetic characterization of primary - relapse pairs by chromosomal copy number and mutational analysis

  2016cites this paper
• Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.

  2016cites this paper
• Thymome

  2016influential citation
• The heterogeneity of follicular lymphomas: from early development to transformation

  2016cites this paper
• LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma.

  2016cites this paper
• New developments in the pathology of malignant lymphoma. A review of the literature published from August 2014 to October 2014

  2014cites this paper